Healthcare provider profile · identity verified

Nupur Verma, MD

Family Practice · GILBERT, AZ · NPI 1780106997

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	306	97
Lisinopril	Lisinopril	183	61
Gabapentin	Gabapentin	165	39
Amlodipine Besylate	Amlodipine Besylate	161	57
Omeprazole	Omeprazole	130	39
Hydrochlorothiazide	Hydrochlorothiazide	128	47
Metformin Hcl	Metformin Hcl	125	43
Pantoprazole Sodium	Pantoprazole Sodium	104	30
Levothyroxine Sodium	Levothyroxine Sodium	103	30
Albuterol Sulfate Hfa	Albuterol Sulfate	99	31
Losartan Potassium	Losartan Potassium	95	34
Sertraline Hcl	Sertraline Hcl	88	22
Metoprolol Succinate	Metoprolol Succinate	81	26
Pravastatin Sodium	Pravastatin Sodium	81	26
Simvastatin	Simvastatin	72	22
Carvedilol	Carvedilol	69	18
Eliquis	Apixaban	68	17
Jardiance	Empagliflozin	67	13
Montelukast Sodium	Montelukast Sodium	65	20
Trazodone Hcl	Trazodone Hcl	65	23
Furosemide	Furosemide	64	15
Warfarin Sodium	Warfarin Sodium	61	12
Bupropion Xl	Bupropion Hcl	59	18
Metoprolol Tartrate	Metoprolol Tartrate	58	19
Fluticasone Propionate	Fluticasone Propionate	45	20
Clopidogrel	Clopidogrel Bisulfate	44	11
Glipizide	Glipizide	44	suppressed
Spironolactone	Spironolactone	44	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	41	14
Buspirone Hcl	Buspirone Hcl	40	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	12
Duloxetine Hcl	Duloxetine Hcl	37	suppressed
Metformin Hcl Er	Metformin Hcl	37	15
Naproxen	Naproxen	37	19
Pregabalin	Pregabalin	37	suppressed
Glipizide Er	Glipizide	33	suppressed
Potassium Chloride	Potassium Chloride	33	suppressed
Tramadol Hcl	Tramadol Hcl	33	16
Allopurinol	Allopurinol	31	suppressed
Famotidine	Famotidine	31	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	31	suppressed
Atenolol	Atenolol	28	11
Ezetimibe	Ezetimibe	28	suppressed
Glimepiride	Glimepiride	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	17
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Prednisone	Prednisone	24	20
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Azithromycin	Azithromycin	21	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Vilazodone Hcl	Vilazodone Hcl	18	suppressed
Fluconazole	Fluconazole	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Metolazone	Metolazone	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Ozempic	Semaglutide	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Linzess	Linaclotide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error